High-throughput screening of a collection of known pharmacologically active small compounds for identification of candida albicans biofilm inhibitors
Open accessAbstract
Candida albicans is the most common etiologic agent of systemic fungal infections with unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and is particularly ineffective against C. albicans biofilms. To address the unmet need for novel antifungals, particularly those active against biofilms, we have screened a small molecule library consisting of 1,200 off-patent drugs already approved by the Food and Drug Administration (FDA), the Prestwick Chemical Library, to identify inhibitors of C. albicans biofilm formation. According to their pharmacological applications that are currently known, we classified these bioactive compounds as antifungal drugs, as antimicrobials/antiseptics, or as miscellaneous drugs, which we considered to be drugs with no previously characterized antifungal activity. Using a 96-well microtiter plate-based high-content screening assay, we identified 38 pharmacologically active agents that inhibit C. albicans biofilm formation. These drugs were subsequently tested for their potency and efficacy against preformed biofilms, and we identified three drugs with novel antifungal activity. Thus, repurposing FDA-approved drugs opens up a valuable new avenue for identification and potentially rapid development of antifungal agents, which are urgently needed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Zotepine inhibits biofilm development in C. albicans at 0.1-40 μM (0.03-12 μg/mL).
“| Zotepine | | | | | | (High affinity to dopamine | | | | | | receptors, affects serotonin receptors, its active metabolite, | C. albicans | 0.1-40 µM (0.03-12 µg/mL) | Inhibits biofilm development | [10] |”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [10]
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · see citing works
Gillum, A. M., Tsay, E. Y. H., & Kirsch, D. R. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00328721 · Cited by 1,253 · see citing works
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202 · see citing works
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150 · see citing works
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · see citing works
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137 · see citing works
<i>Candida</i> Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · see citing works
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041 · see citing works
Self-citationCalderone, R. (2012) · ASM Press eBooks · Cited by 919 · see citing works
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 765 · see citing works
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753 · see citing works
Self-citationAmphotericin B: side effects and toxicity
Laniado-Laborín, R., & Cabrales-Vargas, M. N. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.06.003 · Cited by 739 · see citing works
<i>Candida</i>Biofilms: an Update
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678 · see citing works
Self-citationBrandt, M. E. (2002) · Emerging infectious diseases · doi:10.3201/eid0808.020059 · Cited by 647 · see citing works
<i>Candida</i> biofilms on implanted biomaterials: a clinically significant problem
Ramage, G., MartÃnez, J. P., & López-Ribot, J. L. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00117.x · Cited by 575 · see citing works
Self-citationAntifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 507 · see citing works
Our Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483 · see citing works
Self-citationOverview of medically important antifungal azole derivatives
Fromtling, R. A. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.187 · Cited by 400 · see citing works
Characteristics of biofilm formation by Candida albicans.
Ramage, G., VandeWalle, K., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 370 · see citing works
Self-citationA high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K. K., Chen, S., García‐Rivera, G., Orozco, E., Martínez, M. B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2758 · Cited by 307 · see citing works
In Vitro Activity of Caspofungin against <i>Candida albicans</i> Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288 · see citing works
Self-citationMUKHERJEE, P., & Chandra, J. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.09.002 · Cited by 222 · see citing works
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207 · see citing works
Amphotericin B and Its New Derivatives – Mode of Action
Bagiński, M., & Czub, J. (2009) · Current Drug Metabolism · doi:10.2174/138920009788898019 · Cited by 173 · see citing works
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
Jeon, K., Byun, M.-S., & Jue, D. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.9 · Cited by 173 · see citing works
Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling
Hutter, B., Schaab, C., Albrecht, S., Borgmann, M., Brunner, N. A., Freiberg, C., Ziegelbauer, K. B., Rock, C. O., Ivanov, I., & Loferer, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2838-2844.2004 · Cited by 149 · see citing works
Walraven, C. J., & Lee, S. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01351-12 · Cited by 132 · see citing works
Esumi, H., Lu, J., Kurashima, Y., & Hanaoka, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03330.x · Cited by 127 · see citing works
Geier, D. A., Sykes, L. K., & Geier, M. R. (2007) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400701389875 · Cited by 119 · see citing works
Biofilms of Candida albicans and their associated resistance to antifungal agents.
Ramage, G., Wickes, B. L., & Lopez-Ribot, J. L. (2001) · PubMed · Cited by 114 · see citing works
Self-citationZorko, M. S., & Jerala, R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn270 · Cited by 105 · see citing works
Iwanaga, T., Kobayashi, D., Hirayama, M., Maeda, T., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006056 · Cited by 103 · see citing works
Harder, A. (2002) · Parasitology Research · doi:10.1007/s00436-001-0587-y · Cited by 56 · see citing works
Chan, C.-Y., Prudom, C. E., Raines, S. M., Charkhzarrin, S., Melman, S. D., Haro, L. P. D., Allen, C., Lee, S. A., Sklar, L. A., & Parra, K. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321133 · Cited by 54 · see citing works
Effect of tunicamycin on Candida albicans biofilm formation and maintenance
Pierce, C. G., Thomas, D. P., & Lopez-Ribot, J. L. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn515 · Cited by 52 · see citing works
Self-citationMechanisms of Anthelmintic Action
Sheth, U. K. (1975) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7090-0_19 · Cited by 44 · see citing works
Outcome of Antimicrobial Therapy in Documented Biofilm-Associated Infections
Falagas, M. E., Kapaskelis, A. M., Kouranos, V., Kakisi, O. K., Athanassa, Z., & Karageorgopoulos, D. E. (2009) · Drugs · doi:10.2165/00003495-200969100-00005 · Cited by 40 · see citing works
Bernadette, G. G., Akpa, E. E., Solange, K.-N., Natalie, G., Souleymane, B., Niamke, S. L., & Dosso, M. B. (2012) · International Journal of Microbiology · doi:10.1155/2012/150612 · Cited by 40 · see citing works
Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues
Locuson, C. W., Rock, D. A., & Jones, J. P. (2004) · Biochemistry · doi:10.1021/bi049651o · Cited by 37 · see citing works
Katz, M. (1977) · Drugs · doi:10.2165/00003495-197713020-00002 · Cited by 35 · see citing works
Approaches to Design and Synthesis of Antiparasitic Drugs
(1997) · Pharmacochemistry library · doi:10.1016/s0165-7208(97)x8021-3 · Cited by 32 · see citing works
Chemotherapeutic approaches to nematodes: current knowledge and outlook
Harder, A. (2002) · Parasitology Research · doi:10.1007/s00436-001-0535-x · Cited by 30 · see citing works
A Novel Approach to Combinatorial Library Design
Nilakantan, R. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207024607310 · Cited by 27 · see citing works
3 Final Report on the Safety Assessment of Benzethonium Chloride and Methylbenzethonium Chloride
(1985) · Journal of the American College of Toxicology · doi:10.3109/10915818509078687 · Cited by 23 · see citing works
FDA Regulations for Drug Development
Behrman, R. E., & Woodcock, J. (2010) · Science · doi:10.1126/science.329.5987.33-b · Cited by 8 · see citing works
Yu, X., & Crites, J. L. (1990) · The Knowledge Bank (The Ohio State University) · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Drug repurposing for antimicrobial discovery
Farha, M. A., & Brown, E. D. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0357-1 · Cited by 365 · see citing works
Drug repositioning and repurposing: terminology and definitions in literature
Langedijk, J., Mantel-Teeuwisse, A. K., Slijkerman, D. S., & Schutjens, M.-H. D. B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.001 · Cited by 327 · see citing works
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 294 · see citing works
Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition
Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 210 · see citing works
Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy
Wall, G., & Lopez-Ribot, J. L. (2020) · Antibiotics · doi:10.3390/antibiotics9080445 · Cited by 176 · see citing works
Self-citationAntifungal therapy with an emphasis on biofilms
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & López-Ribot, J. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.008 · Cited by 173 · see citing works
Self-citationPierce, C. G., & Lopez-Ribot, J. L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.807245 · Cited by 158 · see citing works
Self-citationTackling Fungal Resistance by Biofilm Inhibitors
Wu, S., Wang, Y., Liu, N., Dong, G., & Sheng, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01203 · Cited by 134 · see citing works
Pierce, C. G., Chaturvedi, A. K., Lazzell, A. L., Powell, A. T., Saville, S. P., McHardy, S. F., & Lopez-Ribot, J. L. (2015) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2015.12 · Cited by 124 · see citing works
Self-citationLara, H. H., Guisbiers, G., Mendoza, J., Mimun, L. C., Vincent, B., Lopez-Ribot, J. L., & Nash, K. L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151285 · Cited by 104 · see citing works
Self-citationWall, G., Chaturvedi, A. K., Wormley, F. L., Wiederhold, N. P., Patterson, H. P., Patterson, T. F., & Lopez-Ribot, J. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-18 · Cited by 89 · see citing works
Self-citationWiederhold, N. P., Patterson, T. F., Srinivasan, A., Chaturvedi, A. K., Fothergill, A. W., Wormley, F. L., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2016) · Virulence · doi:10.1080/21505594.2016.1196301 · Cited by 88 · see citing works
Self-citationTorres, N. S., Abercrombie, J. J., Srinivasan, A., Lopez-Ribot, J. L., Ramasubramanian, A. K., & Leung, K. P. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-16 · Cited by 86 · see citing works
Self-citationRepurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
May, H. C., Yu, J., Guentzel, M. N., Chambers, J. P., Cap, A. P., & Arulanandam, B. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00336 · Cited by 82 · see citing works
De Cremer, K., Lanckacker, E., Cools, T. L., Bax, M., De Brucker, K., Cos, P., Cammue, B. P. A., & Thevissen, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04229-14 · Cited by 77 · see citing works
Kim, J. H., Cheng, L. W., Chan, K. L., Tam, C. C., Mahoney, N., Friedman, M., Shilman, M. M., & Land, K. M. (2020) · Antibiotics · doi:10.3390/antibiotics9110812 · Cited by 71 · see citing works
de Oliveira, H. C., Monteiro, M. C., Rossi, S. A., Pemán, J., Gaitán, A. C. R., Mendes‐Giannini, M. J. S., Mellado, E., & Zaragoza, Ó. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00083 · Cited by 67 · see citing works
Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
Mamouei, Z., Alqarihi, A., Singh, S., Xu, S., Mansour, M. K., Ibrahim, A. S., & Uppuluri, P. (2018) · mSphere · doi:10.1128/msphere.00539-18 · Cited by 65 · see citing works
Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors
Vila, T. V. M., & Lopez-Ribot, J. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02006-16 · Cited by 64 · see citing works
Self-citationA complex game of hide and seek: the search for new antifungals
Ngo, H., Garneau‐Tsodikova, S., & Green, K. D. (2016) · MedChemComm · doi:10.1039/c6md00222f · Cited by 64 · see citing works
Gerstein, A. C., Rosenberg, A., Hecht, I., & Berman, J. (2016) · Microbiology · doi:10.1099/mic.0.000295 · Cited by 63 · see citing works
Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity
Wall, G., & Lopez-Ribot, J. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00924-20 · Cited by 63 · see citing works
Self-citationInhibition of Bacterial and Fungal Pathogens by the Orphaned Drug Auranofin
Fuchs, B. B., Rajamuthiah, R., Souza, A. C. R., Eatemadpour, S., Rossoni, R. D., Santos, D. A., Junqueira, J. C., Rice, L. B., & Mylonakis, E. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.182 · Cited by 62 · see citing works
Drug repositioning: current approaches and their implications in the precision medicine era
Talevi, A. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1424535 · Cited by 59 · see citing works
Drug Repurposing for the Treatment of Staphylococcal Infections
Thangamani, S., Mohammad, H. T., Younis, W., & Seleem, M. N. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150310104416 · Cited by 58 · see citing works
Summer, K., Browne, J., Hollanders, M., & Benkendorff, K. (2022) · Biofilm · doi:10.1016/j.bioflm.2022.100081 · Cited by 57 · see citing works
Chong, P. P., Chin, V. K., Wong, W. F., Madhavan, P., Yong, P. V. C., & Looi, C. Y. (2018) · Genes · doi:10.3390/genes9110540 · Cited by 56 · see citing works
Torres, N. S., Montelongo‐Jauregui, D., Abercrombie, J. J., Srinivasan, A., Lopez-Ribot, J. L., Ramasubramanian, A. K., & Leung, K. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02541 · Cited by 56 · see citing works
Self-citationAntimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
Caldara, M., & Marmiroli, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090915 · Cited by 54 · see citing works
Antifungal therapy of Candida biofilms: Past, present and future
Ajetunmobi, O. H., Badali, H., Romo, J. A., Ramage, G., & Lopez-Ribot, J. L. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100126 · Cited by 52 · see citing works
Self-citationRossi, S. A., de Oliveira, H. C., Agreda-Mellon, D., Lucio, J., Mendes-Giannini, M. J. S., García-Cambero, J. P., & Zaragoza, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-19 · Cited by 48 · see citing works
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
Kim, K., Zilbermintz, L., & Martchenko, M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0090-4 · Cited by 48 · see citing works
Neto, J. B. D. A., Josino, M. A. A., da Silva, C. R., Campos, R. D. S., do Nascimento, F. B. S. A., Sampaio, L. S., Sá, L. G. D. A. V., Carneiro, I. D. S., Barroso, F. D. D., da Silva, L. J., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.11.056 · Cited by 46 · see citing works
Feng, J., Weitner, M., Shi, W., Zhang, S., Sullivan, D., & Zhang, Y. (2015) · Antibiotics · doi:10.3390/antibiotics4030397 · Cited by 43 · see citing works
Prospects for Anti-Biofilm Pharmaceuticals
Stewart, P. S. (2015) · Pharmaceuticals · doi:10.3390/ph8030504 · Cited by 42 · see citing works
Seth, A. K., Zhong, A., Nguyen, K. T., Hong, S. J., Leung, K. P., Galiano, R. D., & Mustoe, T. A. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12232 · Cited by 40 · see citing works
New and Improved Techniques for the Study of Pathogenic Fungi
Cairns, T. C., Studholme, D. J., Talbot, N. J., & Haynes, K. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.09.008 · Cited by 41 · see citing works
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
de Oliveira, H. C., Bezerra, B. T., & Rodrigues, M. L. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00055 · Cited by 41 · see citing works
Watamoto, T., Egusa, H., Sawase, T., & Yatani, H. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01453 · Cited by 36 · see citing works
Distorted Gold(I)–Phosphine Complexes as Antifungal Agents
Dennis, E. K., Kim, J. H., Parkin, S., Awuah, S. G., & Garneau‐Tsodikova, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01436 · Cited by 36 · see citing works
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0007-2014 · Cited by 35 · see citing works
Self-citationTalevi, A., Carrillo, C., & Comini, M. A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180926151059 · Cited by 34 · see citing works
Strategies in the Discovery of Novel Antifungal Scaffolds
Liu, N., Wang, C., Su, H., Zhang, W., & Sheng, C. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0020 · Cited by 34 · see citing works
Dioscin Inhibits Virulence Factors ofCandida albicans
Yang, L., Liu, X., Zhong, L., Sui, Y., Quan, G., Huang, Y., Wang, F., & Ma, T. (2018) · BioMed Research International · doi:10.1155/2018/4651726 · Cited by 33 · see citing works
Nanomaterial-based therapeutics for enhanced antifungal therapy
Liu, F., Chen, Y., Huang, Y., Jin, Q., & Ji, J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01484g · Cited by 32 · see citing works
den Driessche, F. V., Brackman, G., Swimberghe, R. C. D., Rigole, P., & Coenye, T. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.023 · Cited by 28 · see citing works
Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development
Simm, C., & May, R. C. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00181 · Cited by 26 · see citing works
Antifungal effects of alantolactone on Candida albicans: An in vitro study
Yang, L., Zhong, L., Ma, Z., Sui, Y., Xie, J., Liu, X., & Ma, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112814 · Cited by 26 · see citing works
Current and promising pharmacotherapeutic options for candidiasis
Scorzoni, L., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873951 · Cited by 28 · see citing works
Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication
Bujdáková, H. (2016) · Future Microbiology · doi:10.2217/fmb.15.139 · Cited by 25 · see citing works
Current Research Approaches to Target Biofilm Infections.
Bernardes, E. V. T., Lewenza, S., & Reckseidler-Zenteno, S. (2015) · Postdoc Journal · doi:10.14304/surya.jpr.v3n6.5 · Cited by 25 · see citing works
Liu, S., Yu, J., Creeden, J. F., Sutton, J. M., Markowiak, S. F., Sanchez, R., Nemunaitis, J. J., Nestor‐Kalinoski, A. L., Zhang, J., Damoiseaux, R. D., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.002 · Cited by 24 · see citing works
Scorzoni, L., de Menezes, R. T., Pereira, T. C., OLIVEIRA, P. S., Ribeiro, F. D. C., Santos, E. L. D. S., Fugisaki, L. R. D. O., OLIVEIRA, L. D. D., & Amorim, J. B. O. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200703 · Cited by 25 · see citing works
Wang, C., & Zheng, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875349 · Cited by 22 · see citing works
Halder, V., Suliman, M., Kaschani, F., & Kaiser, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47526-5 · Cited by 21 · see citing works
Synergistic Effects of Ketamine and Azole Derivatives onCandidaSpp. Resistance to Fluconazole
Neto, J. B. D. A., da Silva, C. R., Barroso, F. D. D., Sá, L. G. D. A. V., Campos, R. D. S., do Nascimento, F. B. S. A., Sampaio, L. S., da Silva, A. R., da Silva, L. J., Carneiro, I. D. S., et al. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0082 · Cited by 20 · see citing works
Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds
Beattie, S. R., & Krysan, D. J. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.03.005 · Cited by 20 · see citing works
Novel avenues for identification of new antifungal drugs and current challenges
Jampílek, J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2097659 · Cited by 19 · see citing works
Uppuluri, P., & Lopez-Ribot, J. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_5 · Cited by 18 · see citing works
Self-citationCarrier-Mediated Drug Uptake in Fungal Pathogens
Galocha, M., Costa, I. V., & Teixeira, M. C. (2020) · Genes · doi:10.3390/genes11111324 · Cited by 18 · see citing works
In Silico Drug Repositioning for Chagas Disease
Bellera, C. L., Alberca, L. N., Sbaraglini, M. L., & Talevi, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191016114839 · Cited by 17 · see citing works
Beattie, S. R., & Krysan, D. J. (2021) · mSphere · doi:10.1128/msphere.00539-21 · Cited by 16 · see citing works
Etomidate Inhibits the Growth of MRSA and Exhibits Synergism with Oxacillin
Sá, L. G. D. A. V., da Silva, C. R., Neto, J. B. D. A., Cândido, T. M., de Oliveira, L. C., do Nascimento, F. B. S. A., Barroso, F. D. D., da Silva, L. J., de Mesquita, J. R., de Moraes, M. O., et al. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0078 · Cited by 16 · see citing works
Rollin‐Pinheiro, R., Borba-Santos, L. P., Xisto, M. I. D. D. S., de Castro-Almeida, Y., Rochetti, V. P., Rozental, S., & Barreto‐Bergter, E. (2021) · Journal of Fungi · doi:10.3390/jof7100803 · Cited by 16 · see citing works
García-Barbazán, I., Torres-Cano, A., García-Rodas, R., Sachse, M., Luque, D., Megías, D., & Zaragoza, O. (2024) · mBio · doi:10.1128/mbio.02549-23 · Cited by 14 · see citing works
Zhang, S., Jain, M., Fleites, L. A., Rayside, P. A., & Gabriel, D. W. (2018) · Phytopathology · doi:10.1094/phyto-07-18-0244-fi · Cited by 15 · see citing works
Chen, P., Yang, J., Jin, Y., Lu, C., Feng, Z., Gao, F., Chen, Y., Wang, F., Shang, Z., & Lin, W. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101381 · Cited by 14 · see citing works
An Update on the Global Treatment of Invasive Fungal Infections
Munzen, M. E., Garcia, A. D. G., & Martinez, L. R. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0269 · Cited by 15 · see citing works
Queiroz, H. A., da Silva, C. R., Neto, J. B. D. A., Sá, L. G. D. A. V., do Nascimento, F. B. S. A., Moreno, L. S. S., Barroso, F. D. D., da Silva, L. J., Cândido, T. M., de Oliveira, L. C., et al. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0095 · Cited by 14 · see citing works
Auranofin coated catheters inhibit bacterial and fungal biofilms in a murine subcutaneous model
LewisOscar, F., Whitely, C. B., Tharmalingam, N., Mishra, B., Vera‐González, N., Mylonakis, E. E., Shukla, A., & Fuchs, B. B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1135942 · Cited by 13 · see citing works
Small molecule based anti-virulence approaches against Candida albicans infections
Kalimuthu, S., Alshanta, O. A., Krishnamoorthy, A. L., Pudipeddi, A., Solomon, A. P., McLean, W., Leung, Y. Y., Ramage, G., & Neelakantan, P. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2025337 · Cited by 13 · see citing works
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens
Gaikwad, V. R., Karale, U. B., Govindarajalu, G., Adhikari, N., Krishna, E. V., Krishna, V. S., Misra, S., Sriram, D., Sijwali, P. S., & Rode, H. B. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127037 · Cited by 13 · see citing works
Artemisinin Targets Transcription Factor PDR1 and Impairs Candida glabrata Mitochondrial Function
Zhu, P., Yue, C., Zeng, X., & Chen, X. (2022) · Antioxidants · doi:10.3390/antiox11101855 · Cited by 12 · see citing works
Novel Strategies Against Candida Biofilms: Interest of Synthetic Compounds
Girardot, M., & Imbert, C. (2015) · Future Microbiology · doi:10.2217/fmb.15.118 · Cited by 12 · see citing works
Tharmalingam, N., Xu, S. J., Felix, L. O., Roy, B., Xian, M., Mylonakis, E. E., & Fuchs, B. B. (2023) · Frontiers in Antibiotics · doi:10.3389/frabi.2023.1179354 · Cited by 11 · see citing works
Ajetunmobi, O. H., Wall, G., Bonifácio, B. V., Delgado, L., Chaturvedi, A. K., Najvar, L. K., Wormley, F. L., Patterson, H. P., Wiederhold, N. P., Patterson, T. F., et al. (2023) · Journal of Fungi · doi:10.3390/jof9090879 · Cited by 11 · see citing works
Self-citationLycorine Hydrochloride Inhibits the Virulence Traits ofCandida albicans
Yang, L., Liu, X., Sui, Y., Ma, Z., Feng, X., Wang, F., & Ma, T. (2019) · BioMed Research International · doi:10.1155/2019/1851740 · Cited by 11 · see citing works
Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses
Gómez-Gaviria, M., Contreras-López, L. M., Aguilera-Domínguez, J. I., & Mora-Montes, H. M. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s466336 · Cited by 10 · see citing works
Infectivity and stress tolerance traits affect community assembly of plant pathogenic fungi
Choi, S., Yang, J., Kim, J., Jeon, H., Shin, S., Wui, D., Kim, L. S., Kim, B. J., Son, H., & Min, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1234724 · Cited by 9 · see citing works
Drug Repurposing Strategy against Fungal Biofilms
de Mello, T. P., Silva, L. N., Ramos, L. S., Frota, H. F., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662007200316142626 · Cited by 9 · see citing works
de Oliveira, F. F. M., Paredes, V., de Sousa, H. R., Moura, Á. N. D., Riasco-Palacios, J., Casadevall, A., Felipe, M. S. S., & Nicola, A. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02930 · Cited by 8 · see citing works
Polyphyllin I, a strong antifungal compound against Candida albicans
Zhang, Y., Zhang, J., Sun, J., Zhang, M., Liu, X., Yang, L., & Yin, Y. (2023) · Apmis · doi:10.1111/apm.13353 · Cited by 8 · see citing works
In Vitro Models to Study Candida albicans Biofilms
Gu, W., Xu, D., & Sun, S. (2015) · Journal of Pharmaceutics and Drug Development · doi:10.15744/2348-9782.3.301 · Cited by 8 · see citing works
Park, Y., Srikantha, T., Daniels, K. J., Jacob, M. R., Agarwal, A. K., Li, X., & Soll, D. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01319-17 · Cited by 8 · see citing works
di Punzio, G., Gilberti, M., Baruffini, E., Lodi, T., Donnini, C., & Dallabona, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212223 · Cited by 7 · see citing works
Impeding Virulence of Candida albicans by Candesartan and Domperidone
Abbas, H. A., Gad, A. I., El-Sayed, M. A., & El-Ganiny, A. M. (2021) · Current Microbiology · doi:10.1007/s00284-021-02663-x · Cited by 9 · see citing works
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch19 · Cited by 7 · see citing works
Self-citationMa, J., van de Sande, W. W. J., & Biersack, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167909 · Cited by 6 · see citing works
Perspectives on Anti-Candida Drug Development
Dubey, A. K., & Singla, R. K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/156802661926191114102349 · Cited by 6 · see citing works
El-Demerdash, A. S., & Bakry, N. R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91146 · Cited by 6 · see citing works
Ansari, A., Kumar, D., Gupta, P., Poluri, K. M., Rai, N., Ameen, F., & Kumar, N. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04103-3 · Cited by 6 · see citing works
Praetorius, J., Hitzler, S. U. J., Gresnigt, M. S., & Figge, M. T. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf011 · Cited by 5 · see citing works
Kantiwal, U., & Pandey, J. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04231-w · Cited by 5 · see citing works
Coutinho, T. D. N. P., Barroso, F. D. D., da Silva, C. R., da Silva, A. R., Cabral, V. P. D. F., Sá, L. G. D. A. V., Cândido, T. M., da Silva, L. J., Ferreira, T. L., da Silva, W. M. B., et al. (2021) · Canadian Journal of Microbiology · doi:10.1139/cjm-2021-0093 · Cited by 5 · see citing works
Current and emerging therapies for fungal biofilms and systemic infections
Elgammal, Y., Martinez, R. I. G., Requejo, A., & Martinez, L. R. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2570185 · Cited by 4 · see citing works
SYNTHESIS AND EVALUATION OF THE ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY OF NOVEL DIBENZOTHIEPINES
Stecoza, C. E. (2020) · FARMACIA · doi:10.31925/farmacia.2020.6.17 · Cited by 4 · see citing works
Sampaio, L. S., da Silva, C. R., Campos, R. D. S., do Nascimento, F. B. S. A., Neto, J. B. D. A., da Silva, L. J., Gaspar, B. D. S., Queiroz, H. A., Barroso, F. D. D., de Mesquita, J. R. L., et al. (2018) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2018.703.242 · Cited by 3 · see citing works
Kouga, T., Koizume, S., Aoki, S., Jimbo, E. F., Yamagata, T., Inoue, K., & Osaka, H. (2019) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2019.100474 · Cited by 4 · see citing works
Ridge, Y., Landini, P., & Thompson, A. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13890 · Cited by 4 · see citing works
Moustafa, E. E. (2023) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2023.311650 · Cited by 2 · see citing works
- Authors
- Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K.
- Affiliations
- The University of Texas at San Antonio (US)
- Departments of Biology, The University of Texas at San Antonio, San Antonio, Texas, USA
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-08
- Volume
- 57
- Issue
- 8
- Pages
- 3681-3687
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3719724
- OpenAlex
- W2171146043
- Cited by
- 120
- References
- 47
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 11 · 2021: 10 · 2020: 16 · 2019: 10 · 2018: 14 · 2017: 6 · 2016: 9 · 2015: 14 · 2014: 3 · 2013: 2
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- San Antonio Area Foundation
- National Heart, Lung, and Blood Institute (SC1HL112629)
- National Institute of Dental and Craniofacial Research (R01DE023510)
- Army Research Office
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, biofilm formation, antibiofilm agents, antifungal drug repurposing, FDA-approved drugs, Prestwick Chemical Library, high-content screening, drug discovery, systemic fungal infection
- MeSH terms
- Amphotericin B, Antifungal Agents, Benzethonium, Candida albicans, Dimethyl Sulfoxide, Disinfectants, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Biofilms, Microbial Viability, Small Molecule Libraries, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review